Specialty enzymes have gained popularity in the recent years owing to their potential applications in various industries such as pharmaceutical, biotechnology research and diagnostics. Specialty enzymes are proteins that act as biocatalysts to accelerate reactions and produce the desired results in pharmaceuticals and diagnostics reactions. In the pharmaceuticals industry, specialty enzymes play a major role in drug formulation and drug delivery. Enzyme based pharmaceutical drug formulations are used for the treatment of chronic conditions such as cancer and AIDS. Specialty enzymes have been widely used in the biotechnology industry for research, particularly in the molecular biology. They are also used in genetic engineering techniques to cut, replicate and attach DNA as per requirement. Specialty enzymes play a major role in the diagnosis of diseases such as cancer, cardiovascular diseases and lysosomal disorders. The specialty enzymes required for diagnostics has to be of the highest purity and in small quantity, which results in the high cost and less adoption of diagnostic enzymes.
The increasing applications of enzymes in therapies for chronic diseases, rising demand for effective therapeutics and growing incidences of digestive enzyme disorders are some of the key factors that drive the growth of the global specialty enzymes market for pharmaceuticals, biotechnology research and diagnostics. Factors restraining the market growth are restriction concerning the chemical properties and safety issues arising due to the contamination of enzymes. The global specialty enzymes market for pharmaceuticals, biotechnology research and diagnostics accounted for $561.9 million in 2014 and is forecast to generate $947.5 million by 2020, registering a CAGR of 9.4% during 2015 - 2020.
The global specialty enzymes for pharmaceuticals, biotechnology R&D and diagnostics market is segmented based on the application, source, type and geography. Based on the applications, the market is segmented into pharmaceuticals, biotechnology R&D and diagnostics. Based on the source, the market is segmented into three types, namely microorganisms, plants and animals. The microorganisms segment held a dominant share in the market in 2014 owing to its easy availability, feasibility for large scale production and cost-effectiveness. Microorganisms are easier to cultivate and the quantity of enzyme production can be controlled and estimated. Based on the product type, the market is segmented into acylases, hydratases, humulin, oxidase, lyases, restriction enzymes, ligases, polymerases, lipases, amylases, proteases, dehydrogenases, glucuronidase and others. Acylases enzyme held a dominant share of the market in 2014 owing to its wide and diversified application in the pharmaceutical drug formulations.
Geographically, the specialty enzyme market is segmented into North America, Europe, Asia-Pacific and LAMEA regions. North America region had the largest market for the specialty enzymes in 2014 due to the presence of large number of biopharmaceutical companies in the U.S. and favorable government regulations. High prevalence rates of digestive disorders would also fuel the demand for the digestive aids and supplements in the North America specialty enzymes market. The key companies profiled in this report include, Novozymes, DuPont, F. Hoffmann-La Roche AG, BASF, Life technologies, Advance enzyme Technologies Ltd, Affymetrix, Inc., and Codexis, Inc.
KEY MARKET BENEFITS:
KEY MARKET SEGMENTS:
The specialty enzymes market is segmented as below:
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research Methodology
1.4.1 Primary research
1.4.2 Secondary research
1.4.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market definition and scope
3.2 Enzyme extraction processes
3.2.1 Filtration
3.2.2 Centrifugation and sedimentation:
3.2.3 Purification:
3.3 Key findings
3.3.1 Top impacting factors
3.3.2 Top investment pockets
3.3.3 Top winning strategies
3.4 Government regulations
3.5 Value chain analysis
3.5.1.1 Primary Activities
3.5.1.2 Supportive Activities
3.6 Market share analysis, 2014
3.7 Clinical trials
3.8 Patent analysis (2010-2014)
3.8.1 Patent analysis by geographies (2010-2014)
3.8.2 Patent analysis by sub segment (2010-2014)
3.9 Market dynamics
3.9.1 Drivers
3.9.2 Restraints
3.9.3 Opportunities
CHAPTER 4 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET, BY APPLICATION 2014-2020,
4.1 Pharmaceuticals
4.1.1 Key market trends
4.1.2 Market growth factors and opportunities
4.1.3 Market size and forecast
4.2 Biotechnology research and development
4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.3 Diagnostics
4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
CHAPTER 5 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY SOURCE, 2014-2020,
5.1 Microorganisms
5.1.1 Key market trends
5.1.2 Market growth factors and opportunities
5.1.3 Market size and forecast
5.2 Plants
5.2.1 Key market trends
5.2.2 Market growth factors and opportunities
5.2.3 Market size and forecast
5.3 Animal
5.3.1 Key market trends
5.3.2 Market growth factors and opportunities
5.3.3 Market size and forecast
CHAPTER 6 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY TYPE, 2014-2020,
6.1 Overview
6.1.1 Market size and forecast
6.2 Acylases
6.2.1 Market size and forecast
6.3 Hydratases
6.3.1 Market size and forecast
6.4 Humulin
6.4.1 Market size and forecast
6.5 Oxidase
6.5.1 Market size and forecast
6.6 Lyases
6.6.1 Market size and forecast
6.7 Restriction enzymes
6.7.1 Market size and forecast
6.8 Ligases
6.8.1 Market size and forecast
6.9 Polymerases
6.9.1 Market size and forecast
6.10 Lipases
6.10.1 Market size and forecast
6.11 Amylases
6.11.1 Market size and forecast
6.12 Proteases
6.12.1 Market size and forecast
6.13 Dehydrogenases
6.13.1 Market size and forecast
6.14 Glucuronidases
6.14.1 Market size and forecast
6.15 Others
6.15.1 Market size and forecast
CHAPTER 7 GLOBAL SPECIALTY ENZYMES FOR PHARMACEUTICALS, BIOTECH R&D AND DIAGNOSTICS MARKET BY GEOGRAPHY, 2014-2020,
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key market trends
7.2.2 Competitive scenario
7.2.3 Key growth factors and opportunities
7.2.4 Market size and forecast
7.3 Europe
7.3.1 Key market trends
7.3.2 Competitive scenario
7.3.3 Key growth factors and opportunities
7.3.4 Market size and forecast
7.4 Asia-Pacific
7.4.1 Key market trends
7.4.2 Competitive scenario
7.4.3 Key growth factors and opportunities
7.4.4 Market size and forecast
7.5 LAMEA
7.5.1 Key market trends
7.5.2 Competitive scenario
7.5.3 Key growth factors and opportunities
7.5.4 Market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Roche Holding AG
8.1.1 Overview
8.1.2 Company snapshot of Roche Holding Ag
8.1.3 Financial performance of Roche Holding Ag.
8.1.4 Strategic moves and developments
8.1.5 SWOT analysis of Roche Holding Ag.
8.2 Sanofi S.A.
8.2.1 Overview
8.2.2 Company snapshot Sanofi S.A.
8.2.3 Financial performance
8.2.4 Strategic moves and developments
8.2.5 SWOT analysis of Sanofi SA
8.3 BASF
8.3.1 Overview
8.3.2 Company snapshot
8.3.3 Financial performance
8.3.4 Strategic moves and developments
8.3.5 SWOT analysis of BASF
8.4 Advanced Enzyme Technology Ltd.
8.4.1 Overview
8.4.2 Company snapshot
8.4.3 Financial performance
8.4.4 Strategic moves and developments
8.4.5 SWOT analysis of Advanced Enzymes Technologies
8.5 BBI Enzymes Ltd.
8.5.1 Overview
8.5.2 Company snapshot.
8.5.3 Strategic moves and developments
8.5.4 SWOT analysis
8.6 Affymetrix Inc.
8.6.1 Overview
8.6.2 Company snapshot
8.6.3 Financial performance
8.6.4 Strategic moves and developments
8.6.5 SWOT analysis
8.7 Codexis Inc.
8.7.1 Overview
8.7.2 Company snapshot
8.7.3 Financial performance
8.7.4 Strategic moves and developments
8.7.5 SWOT analysis.
8.8 Novozymes
8.8.1 Overview
8.8.2 Company snapshot
8.8.3 Financial performance
8.8.4 Strategic moves and developments
8.8.5 SWOT analysis
8.9 DuPont
8.9.1 DuPont Overview
8.9.2 Company snapshot
8.9.3 Financial performance
8.9.4 Strategic moves and developments
8.9.5 Swot analysis
8.10 AB Enzymes
8.10.1 Ab Enzymes Overview
8.10.2 Company snapshot
8.10.3 Strategic moves and developments
8.10.4 Swot analysis
List of Figures
FIG. 1 MODERATE GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
FIG. 2 RAPID GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
FIG. 3 DIMINISHING GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
FIG. 4 TOP FACTORS IMPACTING GLOBAL SPECIALTY ENZYMES MARKET (2014-2020)
FIG. 5 TOP INVESTMENT POCKETS OF GLOBAL SPECIALTY ENZYMES MARKET
FIG. 6 TOP WINNING STRATEGIES IN SPECIALTY ENZYMES MARKET DURING 2010-2014
FIG. 7 VALUE CHAIN FOR SPECIALTY ENZYMES INDUSTRY
FIG. 8 MARKET SHARE ANALYSIS, 2014
FIG. 9 PATENT ANALYSIS BY GEOGRAPHIES (2010-2014)
FIG. 10 PATENT ANALYSIS BY SUB SEGMENT
FIG. 11 ROCHE REVENUE BY SEGMENT (2014)
FIG. 12 ROCHE HOLDING AG’S REVENUE BY REGION (2014)
FIG. 13 SWOT ANALYSIS OF ROCHE HOLDING AG.
FIG. 14 SANOFI SA’S REVENUE BY BUSINESS SEGMENTS (2014)
FIG. 15 SWOT ANALYSIS OF SANOFI S.A.
FIG. 16 BASF REVENUE BY GEOGRAPHY (2014)
FIG. 17 BASF REVENUE BY SEGMENTS (2014)
FIG. 18 SWOT ANALYSIS OF BASF
FIG. 19 ADVANCED ENZYMES TECHNOLOGIES REVENUE (2011-2013)
FIG. 20 ADVANCED ENZYMES TECHNOLOGIES REVENUE BY GEOGRAPHY
FIG. 21 SWOT ANALYSIS OF BBI ENZYMES LTD.
FIG. 22 AFFYMETRIX REVENUE $MILLION (2012- 2014)
FIG. 23 SWOT ANALYSIS OF AFFYMETRIX
FIG. 24 CODEXIS REVENUE $MILLION (2012-2014)
FIG. 25 SWOT ANALYSIS OF CODEXIS INC.
FIG. 26 NOVOZYMES REVENUE $MILLION (2012-2014)
FIG. 27 NOVOZYME REVENUE BY SEGMENT
FIG. 28 NOVOZYME REVENUE BY GEOGRAPHY
FIG. 29 SWOT ANALYSIS OF NOVOZYMES
FIG. 30 FINANCIAL REVENUE OF DUPONT BY BUSINESS SEGMENT (2014)
FIG. 31 SWOT ANALYSIS OF DUPONT
FIG. 32 SWOT ANALYSIS OF AB ENZYMES
List of Tables
TABLE 1 MODERATE GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 2 RAPID GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 3 DIMINISHING GROWTH SCENARIO OF GLOBAL SPECIALTY ENZYMES MARKET, BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 4 CLINICAL TRIALS
TABLE 5 TYPES OF ENZYMES AND ITS APPLICATION
TABLE 6 ENZYMES GRADE SYSTEM
TABLE 7 GLOBAL SPECIALTY ENZYMES MARKET BY APPLICATION, 2014-2020, ($MILLION)
TABLE 8 GLOBAL PHARMACEUTICALS SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 9 GLOBAL BIOTECH R&D SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 10 GLOBAL DIAGNOSTICS SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 11 GLOBAL SPECIALTY ENZYME MARKET, BY SOURCE, 2014-2020, ($MILLION)
TABLE 12 TYPES OF COMMERCIAL ENZYMES AND ITS SOURCE
TABLE 13 GLOBAL MICROORGANISMS DERIVED SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 14 GLOBAL PLANT DERIVED SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 15 GLOBAL ANIMAL DERIVED SPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020, ($MILLION)
TABLE 16 GLOBAL SPECIALTY ENZYMES MARKET BY TYPES, 2014-2020 ($MILLION)
TABLE 17 GLOBAL ACYLASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 18 GLOBAL HYDRATASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 19 GLOBAL HUMULIN ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 20 GLOBAL OXIDASE ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 21 GLOBAL LYASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 22 GLOBAL RETRICTION ENZYMES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 23 GLOBAL LIGASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 24 GLOBAL POLYMERASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 25 GLOBAL LIPASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 26 GLOBAL AMYLASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 27 GLOBAL PROTEASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 28 GLOBAL DEHYDROGENASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 29 GLOBAL GLUCURONIDASES ENZYME MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 30 GLOBAL OTHER ENZYMES MARKET, BY GEOGRAPHY, 2014-2020 ($MILLION)
TABLE 31 GLOBALSPECIALTY ENZYMES MARKET BY GEOGRAPHY, 2014-2020
TABLE 32 NORTH AMERICAN SPECIALTY ENZYMES MARKET, BY APPLICATION, 2014-2020, ($MILLION)
TABLE 33 EUROPE SPECIALTY ENZYMES MARKET, BY APPLICATION, 2014-2020, ($MILLION)
TABLE 34 ASIA PACIFIC SPECIALTY ENZYMES MARKET, BY APPLICATION, 2014-2020, ($MILLION)
TABLE 35 LAMEA SPECIALTY ENZYMES MARKET, BY APPLICATION, 2014-2020, ($MILLION)
TABLE 36 COMPANY SNAPSHOT OF ROCHE HOLDING AG
TABLE 37 COMPANY SNAPSHOT OF SANOFI S.A.
TABLE 38 COMPANY SNAPSHOT OF BASF
TABLE 39 COMPANY SNAPSHOT OF ADVANCED ENZYME TECHNOLOGY LTD.
TABLE 40 COMPANY SNAPSHOT OF BBI ENZYMES LTD.
TABLE 41 COMPANY SNAPSHOT OF AFFYMETRIX INC.
TABLE 42 COMPANY SNAPSHOT OF CODEXIS INC.
TABLE 43 COMPANY SNAPSHOT OF NOVOZYMES
TABLE 44 COMPANY SNAPSHOT OF DUPONT
TABLE 45 COMPANY SNAPSHOT OF AB ENZYMES
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : November 2019
$ 3600
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
Published On : October 2019
$ 2950
